This company has been marked as potentially delisted and may not be actively trading. Cleveland BioLabs (CBLI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CBLI vs. SCPS, EVLO, CMRA, ARDS, STAB, CALA, PXMD, AMPE, EFTR, and MTEMShould you be buying Cleveland BioLabs stock or one of its competitors? The main competitors of Cleveland BioLabs include Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Calithera Biosciences (CALA), PaxMedica (PXMD), Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), and Molecular Templates (MTEM). These companies are all part of the "medical" sector. Cleveland BioLabs vs. Scopus BioPharma Evelo Biosciences Comera Life Sciences Aridis Pharmaceuticals Statera Biopharma Calithera Biosciences PaxMedica Ampio Pharmaceuticals eFFECTOR Therapeutics Molecular Templates Cleveland BioLabs (NASDAQ:CBLI) and Scopus BioPharma (NASDAQ:SCPS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment. Does the media refer more to CBLI or SCPS? In the previous week, Cleveland BioLabs' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score. Company Overall Sentiment Cleveland BioLabs Neutral Scopus BioPharma Neutral Which has better valuation & earnings, CBLI or SCPS? Cleveland BioLabs has higher revenue and earnings than Scopus BioPharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCleveland BioLabs$260K0.00-$2.40MN/AN/AScopus BioPharmaN/AN/A-$11.61MN/AN/A Is CBLI or SCPS more profitable? Scopus BioPharma's return on equity of 0.00% beat Cleveland BioLabs' return on equity.Company Net Margins Return on Equity Return on Assets Cleveland BioLabsN/A -32.84% -31.29% Scopus BioPharma N/A N/A N/A Which has more risk and volatility, CBLI or SCPS? Cleveland BioLabs has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Scopus BioPharma has a beta of -0.27, suggesting that its stock price is 127% less volatile than the S&P 500. Does the MarketBeat Community favor CBLI or SCPS? Cleveland BioLabs received 274 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 55.20% of users gave Cleveland BioLabs an outperform vote. CompanyUnderperformOutperformCleveland BioLabsOutperform Votes27655.20% Underperform Votes22444.80% Scopus BioPharmaOutperform Votes2100.00% Underperform VotesNo Votes Do insiders & institutionals have more ownership in CBLI or SCPS? 5.1% of Cleveland BioLabs shares are held by institutional investors. 1.0% of Cleveland BioLabs shares are held by company insiders. Comparatively, 5.1% of Scopus BioPharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryCleveland BioLabs beats Scopus BioPharma on 5 of the 9 factors compared between the two stocks. Remove Ads Get Cleveland BioLabs News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLI vs. The Competition Export to ExcelMetricCleveland BioLabsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$6.20B$5.15B$7.06BDividend YieldN/A2.87%4.99%4.17%P/E RatioN/A6.7720.7717.35Price / SalesN/A185.74357.4488.00Price / CashN/A65.6738.1534.64Price / BookN/A5.506.153.76Net Income-$2.40M$141.14M$3.19B$247.27M Cleveland BioLabs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLICleveland BioLabsN/AN/AN/AN/A$5,000.00$260,000.000.004Gap DownSCPSScopus BioPharmaN/A$0.00flatN/A-50.0%$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-98.8%$9,000.00N/A0.00120CMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$1.00M0.002ARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$5,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/AN/A$5,000.00N/A0.0020CALACalithera BiosciencesN/A$0.00flatN/A-97.0%$3,000.00N/A0.0060PXMDPaxMedicaN/A$0.00flatN/AN/A$2,000.00N/A0.002AMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.9%$1,000.00N/A0.0020EFTReFFECTOR TherapeuticsN/A$0.00flatN/A-100.0%$1,000.00$3.55M0.0010MTEMMolecular Templates0.9645 of 5 stars$0.00-50.0%N/A-100.0%$1,000.00$23.48M0.00260Gap Down Remove Ads Related Companies and Tools Related Companies Scopus BioPharma Alternatives Evelo Biosciences Alternatives Comera Life Sciences Alternatives Aridis Pharmaceuticals Alternatives Statera Biopharma Alternatives Calithera Biosciences Alternatives PaxMedica Alternatives Ampio Pharmaceuticals Alternatives eFFECTOR Therapeutics Alternatives Molecular Templates Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLI) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cleveland BioLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cleveland BioLabs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLI Stock Free CBLI Stock Alerts